No, osteoporosis is not an autoimmune disease. It is classified as a metabolic bone disease: bone breakdown outpaces bone formation, usually because of aging, falling estrogen, nutrition, or medications. The immune system is not attacking bone the way it attacks joints in rheumatoid arthritis. That said, the immune system and bone are closely linked, and autoimmune diseases are an important cause of bone loss, which is why the question comes up so often.
This article explains what separates osteoporosis from true autoimmune disease, where the two overlap, and what that overlap means if you live with an autoimmune condition.
What Makes a Disease “Autoimmune”?
In an autoimmune disease, the immune system mistakes the body’s own tissue for a threat. It produces autoantibodies or activated immune cells that target a specific organ or tissue. Examples include rheumatoid arthritis (joints), type 1 diabetes (insulin-producing cells), and Hashimoto’s thyroiditis (the thyroid).
Doctors usually confirm an autoimmune disease by finding characteristic autoantibodies, signs of tissue inflammation, and a response to treatments that calm the immune system. Many conditions are wrongly assumed to be autoimmune; our article asking whether sickle cell disease is an autoimmune condition walks through the same distinction for a blood disorder.
Why Osteoporosis Is Classified Differently
Osteoporosis is defined by low bone mass and deterioration of bone microarchitecture, leading to fragile bones and fractures of the hip, spine, and wrist. It fails the main tests for autoimmunity:
- There is no specific autoantibody that causes or diagnoses it.
- Bone is not infiltrated by attacking immune cells.
- Immunosuppressive drugs do not treat it. In fact, steroids used to suppress the immune system are a leading cause of bone loss.
- Its main drivers, including menopause, aging, low calcium and vitamin D, and inactivity, are metabolic and hormonal.
| Feature | Osteoporosis | Typical autoimmune disease |
|---|---|---|
| Core problem | Imbalance between bone resorption and formation | Immune attack on the body’s own tissue |
| Autoantibodies | None characteristic | Usually present (for example, rheumatoid factor, ANA) |
| Main diagnostic test | DEXA scan (T-score of -2.5 or lower) | Blood antibody tests, clinical findings, biopsy |
| Main treatments | Bisphosphonates, denosumab, anabolic agents, calcium and vitamin D | Immunosuppressants, biologics, steroids |
| Inflammation | Not a defining feature | Central to the disease |
Where the Immune System and Bone Overlap
The reason researchers keep asking the question is that bone cells and immune cells speak the same chemical language. The field that studies this is called osteoimmunology.
Bone is constantly remodeled by two cell types. Osteoclasts, which dissolve bone, actually come from the same family of white blood cells as macrophages, and they form in the bone marrow. Osteoblasts build new bone. Our detailed look at the pathophysiology of osteoporosis explains this cycle step by step.
The RANKL pathway
Osteoclast formation depends on a signal called RANKL binding to its receptor, RANK. A decoy protein, osteoprotegerin (OPG), blocks RANKL and protects bone. Activated immune cells, particularly certain T cells, can produce RANKL, which is one way inflammation speeds up bone breakdown.
The medicine denosumab is an antibody that blocks RANKL, so a treatment born from immune research is now standard osteoporosis therapy. This is an elegant overlap, but it does not make osteoporosis an autoimmune disease.
Inflammatory cytokines
Signaling proteins such as TNF-alpha, interleukin-1, and interleukin-6 promote osteoclast activity. When estrogen falls after menopause, levels of some of these cytokines rise, which helps explain the rapid bone loss of early menopause. Chronic inflammation from any cause can therefore accelerate the progression of osteoporosis.
Autoimmune Diseases That Raise Osteoporosis Risk
While osteoporosis is not autoimmune, many autoimmune diseases cause secondary osteoporosis. They do so through three main routes: inflammation itself, reduced mobility, and treatment with glucocorticoids.
- Rheumatoid arthritis: joint inflammation causes bone loss both around joints and throughout the skeleton.
- Systemic lupus erythematosus: inflammation, steroid use, and avoidance of sunlight (which lowers vitamin D) all contribute.
- Celiac disease and inflammatory bowel disease: poor absorption of calcium and vitamin D weakens bone.
- Type 1 diabetes: associated with lower bone quality and higher fracture risk.
- Autoimmune thyroid disease: an overactive thyroid, or excessive thyroid hormone replacement, speeds bone turnover.
- Ankylosing spondylitis: spinal inflammation and stiffness increase the risk of vertebral fractures.
Long-term glucocorticoids such as prednisone deserve special mention. They reduce bone formation and increase fracture risk, and bone loss is fastest in the first months of treatment. Anyone expected to take steroids for three months or longer should have their bone health reviewed.
Diagnosis and Treatment When Both Are Present
Osteoporosis is diagnosed the same way whether or not an autoimmune disease is present: with a DEXA scan and a fracture risk assessment such as FRAX, which includes rheumatoid arthritis and steroid use as risk factors. Blood tests check calcium, vitamin D, kidney function, and thyroid function.
Treatment combines controlling the underlying autoimmune disease with standard bone therapy. Good disease control reduces inflammation and may allow lower steroid doses, which helps bone directly. Bone-specific options include bisphosphonates, denosumab, and, for those at very high risk, anabolic agents such as teriparatide.
Adequate calcium and vitamin D remain the foundation. Our guide to the role of supplements in osteoporosis management covers dosing considerations, and our article on managing osteoporosis and hip pain at night addresses a common symptom that brings patients to clinic.
Key Takeaways
- Osteoporosis is a metabolic bone disease, not an autoimmune disease.
- Immune signals such as RANKL and inflammatory cytokines strongly influence bone breakdown.
- Autoimmune diseases and the steroids used to treat them are common causes of secondary osteoporosis.
- People with autoimmune conditions benefit from early bone density testing and fracture prevention.
For a full overview of diagnosis, prevention, and treatment, see our osteoporosis guide.
Frequently Asked Questions
Is osteoporosis an inflammatory disease?
Not primarily. Inflammation can accelerate bone loss, and chronic inflammatory diseases raise risk, but most osteoporosis results from aging and hormonal change. It is best described as a metabolic bone disease with immune influences.
Can an autoimmune disease cause osteoporosis?
Yes. Rheumatoid arthritis, lupus, celiac disease, inflammatory bowel disease, and others can lead to secondary osteoporosis. The disease itself, reduced activity, poor nutrient absorption, and steroid treatment all play a part.
Should I get a bone scan if I have rheumatoid arthritis?
Many people with rheumatoid arthritis should, especially if they take steroids, are postmenopausal, or have had a fracture. Ask your rheumatologist or primary care doctor whether a DEXA scan is appropriate for you.
Does treating my autoimmune disease help my bones?
Usually, yes. Controlling inflammation reduces the signals that drive bone breakdown and can allow lower steroid doses. Bone-specific treatment is still often needed alongside it.
